U.S. Army Medical Research and Materiel Command &
Fort Detrick Public Affairs/Marketing Office, Fort Detrick, Maryland
January 23, 2004
For Immediate Release:
Department of Defense Chronic Myelogenous Leukemia Research Program Funding Opportunities for Fiscal Year 2004
The Fiscal Year 2004 (FY04) Defense Appropriations Act provides $4.25 million for the Department of Defense Chronic Myelogenous Leukemia Research Program (CMLRP). This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of Congressionally Directed Medical Research Programs (CDMRP).
The FY04 CMLRP Program Announcement for proposals is expected to be released in early to mid-February 2004 and includes the following mechanism:
Therapeutic Development Awards. These awards are intended to fund the preclinical assessment of novel, potential therapeutics for Chronic Myelogenous Leukemia (CML), as well as the development of tools and model systems of CML for preclinical evaluation. The ultimate goal is to significantly move closer to the development of new therapeutics for CML. These awards may fund goal-focused, synergistic, multi-institutional consortia. All applicants must include preliminary data relevant to the phase(s) of the preclinical drug development process covered by the proposal. Independent investigators in CML research are eligible to apply. There are no total dollar restrictions, although prioity will be given to smaller-scale, cost-efficient projects with well-defined end-points. Funding can be requested for up to 3 years. The Program Announcement is planned for release in early to mid-Febuary and the submission deadline is set for July 27, 2004.
A detailed description of this mechanism, including evaluation criteria, specific submission requirements, and deadlines will be available in the FY04 CMLRP Program Announcement. This Program Announcement will be available electronically for downloading from the CDMRP web site upon its release in early to mid-February 2004.
Requests for e-mail notification when Program Announcements are released may be sent to firstname.lastname@example.org. For more information about the CMLRP, prior CMLRP awardees, previous CMLRP Program Announcements, and other CDMRP-sponsored programs and events, please visit our web site.
Points of Contact:
Gail Whitehead, Public Affairs Coordinator, 301-619-7783, email@example.com
Melissa Forsythe, Ph.D., CMLRP Program Manager, 301-619-7071